ESSENTIAL FUNCTIONS AND RESPONSIBILITIES:
- Develop and execute pharmacovigilance strategies in alignment with Janux’s clinical and regulatory goals.
- Represent Janux in safety-related interactions with global health authorities (e.g., FDA, EMA, APAC).
- Lead the development and implementation of safety management plans, risk management plans (RMPs), and signal detection strategies.
- Ensure safety is proactively integrated into clinical development and decision-making processes.
- Oversee the collection, evaluation, and reporting of adverse events (AEs) and serious adverse events (SAEs) from clinical trials.
- Manage external PV vendors and ensure timely, high-quality execution of contracted activities.
- Maintain a central repository and program plan for all PV activities and deliverables.
- Ensure readiness and execution of safety procedures in response to emerging safety concerns.
- Author and review PV-related documents including DSURs, SMPs, RMPs, RSIs, and safety sections of clinical protocols and study reports.
- Ensure compliance with global PV regulations (FDA, EMA, APAC, ICH, GVP) and internal SOPs.
- Monitor and ensure adherence to PV agreements and safety data exchange agreements (SDEAs) with partners.
- Support internal audits and regulatory inspections; conduct root cause analyses and implement CAPAs as needed.
- Serve as the safety representative in cross-functional teams, including clinical, regulatory, and medical affairs.
- Educate internal teams on evolving safety regulations and best practices.
- Lead or contribute to internal safety review meetings, DSMBs, and safety advisory committees.
- Other duties as deemed necessary
EDUCATION, EXPERIENCE, KNOWLEDGE, SKILLS AND ABILITIES
- Graduate-level degree in life sciences, RN, or equivalent health-related training; MD or PharmD preferred.
- 8+ years of pharmacovigilance experience in the biotech or pharmaceutical industry, including proven leadership roles.
- Strong knowledge of global PV regulations (FDA, EMA, APAC, ICH, GVP).
- Experience in signal management, safety data interpretation, and regulatory reporting.
- Oncology and autoimmune experience will be prioritized in this role.
- MPH or pharmacoepidemiology training desirable.
- Demonstrated ability to lead cross-functional safety initiatives and influence decision-making.
- Excellent communication, analytical, and organizational skills.
- Proficiency in safety databases (e.g., Argus, ARISg) and MedDRA coding.
- Ability to travel domestically and internationally as needed.
Top Skills
What We Do
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.








